Global Dry Eye Syndrome Market Size, Share, Trends and Forecast 2022-2030

Description

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.

Industry Insights

Due to the COVID-19 pandemic, the global Dry Eye Syndrome market size is estimated to be worth US$ 5385 million in 2021 and is forecast to a readjusted size of US$ 7355.1 million by 2028 with a CAGR of 4.5% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Dry Eye Syndrome market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Dry Eye Syndrome landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.

North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.

In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.

This report focuses on Dry Eye Syndrome volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Dry Eye Syndrome market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Dry Eye Syndrome market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Artificial Tears

Anti-inflammatory Drugs

Others

Segment by Distribution Channel

Hospital

Retail Pharmacy

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Allergan

Alcon

Novartis

Santen Pharma

Johnson & Johnson

Bausch & Lomb

Thea pharmaceuticals

URSAPHARM

SIMILASAN

Akorn

United Laboratories

Sun Pharmaceutical

Jianfeng Group

TABLE OF CONTENT

1 Dry Eye Syndrome Market Overview
1.1 Product Overview and Scope of Dry Eye Syndrome

1.2 Dry Eye Syndrome Segment by Type

1.2.1 Global Dry Eye Syndrome Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Artificial Tears

1.2.3 Anti-inflammatory Drugs

1.2.4 Others

1.3 Dry Eye Syndrome Segment by Distribution Channel

1.3.1 Global Dry Eye Syndrome Sales Comparison by Distribution Channel: (2022-2028)

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Global Dry Eye Syndrome Market Size Estimates and Forecasts

1.4.1 Global Dry Eye Syndrome Revenue 2017-2028

1.4.2 Global Dry Eye Syndrome Sales 2017-2028

1.4.3 Dry Eye Syndrome Market Size by Region: 2017 Versus 2021 Versus 2028

2 Dry Eye Syndrome Market Competition by Manufacturers

2.1 Global Dry Eye Syndrome Sales Market Share by Manufacturers (2017-2022)

2.2 Global Dry Eye Syndrome Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Dry Eye Syndrome Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Dry Eye Syndrome Manufacturing Sites, Area Served, Product Type

2.5 Dry Eye Syndrome Market Competitive Situation and Trends

2.5.1 Dry Eye Syndrome Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Dry Eye Syndrome Players Market Share by Revenue

2.5.3 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Dry Eye Syndrome Retrospective Market Scenario by Region

3.1 Global Dry Eye Syndrome Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Dry Eye Syndrome Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Dry Eye Syndrome Market Facts & Figures by Country

3.3.1 North America Dry Eye Syndrome Sales by Country

3.3.2 North America Dry Eye Syndrome Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Dry Eye Syndrome Market Facts & Figures by Country

3.4.1 Europe Dry Eye Syndrome Sales by Country

3.4.2 Europe Dry Eye Syndrome Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Region

3.5.1 Asia Pacific Dry Eye Syndrome Sales by Region

3.5.2 Asia Pacific Dry Eye Syndrome Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Dry Eye Syndrome Market Facts & Figures by Country

3.6.1 Latin America Dry Eye Syndrome Sales by Country

3.6.2 Latin America Dry Eye Syndrome Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Country

3.7.1 Middle East and Africa Dry Eye Syndrome Sales by Country

3.7.2 Middle East and Africa Dry Eye Syndrome Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Dry Eye Syndrome Historic Market Analysis by Type

4.1 Global Dry Eye Syndrome Sales Market Share by Type (2017-2022)

4.2 Global Dry Eye Syndrome Revenue Market Share by Type (2017-2022)

4.3 Global Dry Eye Syndrome Price by Type (2017-2022)

5 Global Dry Eye Syndrome Historic Market Analysis by Distribution Channel

5.1 Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2017-2022)

5.2 Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2017-2022)

5.3 Global Dry Eye Syndrome Price by Distribution Channel (2017-2022)

6 Key Companies Profiled

6.1 Allergan

6.1.1 Allergan Corporation Information

6.1.2 Allergan Description and Business Overview

6.1.3 Allergan Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Allergan Dry Eye Syndrome Product Portfolio

6.1.5 Allergan Recent Developments/Updates

6.2 Alcon

6.2.1 Alcon Corporation Information

6.2.2 Alcon Description and Business Overview

6.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Alcon Dry Eye Syndrome Product Portfolio

6.2.5 Alcon Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Corporation Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Novartis Dry Eye Syndrome Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Santen Pharma

6.4.1 Santen Pharma Corporation Information

6.4.2 Santen Pharma Description and Business Overview

6.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Santen Pharma Dry Eye Syndrome Product Portfolio

6.4.5 Santen Pharma Recent Developments/Updates

6.5 Johnson & Johnson

6.5.1 Johnson & Johnson Corporation Information

6.5.2 Johnson & Johnson Description and Business Overview

6.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Johnson & Johnson Dry Eye Syndrome Product Portfolio

6.5.5 Johnson & Johnson Recent Developments/Updates

6.6 Bausch & Lomb

6.6.1 Bausch & Lomb Corporation Information

6.6.2 Bausch & Lomb Description and Business Overview

6.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Bausch & Lomb Dry Eye Syndrome Product Portfolio

6.6.5 Bausch & Lomb Recent Developments/Updates

6.7 Thea pharmaceuticals

6.6.1 Thea pharmaceuticals Corporation Information

6.6.2 Thea pharmaceuticals Description and Business Overview

6.6.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Thea pharmaceuticals Dry Eye Syndrome Product Portfolio

6.7.5 Thea pharmaceuticals Recent Developments/Updates

6.8 URSAPHARM

6.8.1 URSAPHARM Corporation Information

6.8.2 URSAPHARM Description and Business Overview

6.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.8.4 URSAPHARM Dry Eye Syndrome Product Portfolio

6.8.5 URSAPHARM Recent Developments/Updates

6.9 SIMILASAN

6.9.1 SIMILASAN Corporation Information

6.9.2 SIMILASAN Description and Business Overview

6.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.9.4 SIMILASAN Dry Eye Syndrome Product Portfolio

6.9.5 SIMILASAN Recent Developments/Updates

6.10 Akorn

6.10.1 Akorn Corporation Information

6.10.2 Akorn Description and Business Overview

6.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Akorn Dry Eye Syndrome Product Portfolio

6.10.5 Akorn Recent Developments/Updates

6.11 United Laboratories

6.11.1 United Laboratories Corporation Information

6.11.2 United Laboratories Dry Eye Syndrome Description and Business Overview

6.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.11.4 United Laboratories Dry Eye Syndrome Product Portfolio

6.11.5 United Laboratories Recent Developments/Updates

6.12 Sun Pharmaceutical

6.12.1 Sun Pharmaceutical Corporation Information

6.12.2 Sun Pharmaceutical Dry Eye Syndrome Description and Business Overview

6.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Sun Pharmaceutical Dry Eye Syndrome Product Portfolio

6.12.5 Sun Pharmaceutical Recent Developments/Updates

6.13 Jianfeng Group

6.13.1 Jianfeng Group Corporation Information

6.13.2 Jianfeng Group Dry Eye Syndrome Description and Business Overview

6.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Jianfeng Group Dry Eye Syndrome Product Portfolio

6.13.5 Jianfeng Group Recent Developments/Updates

7 Dry Eye Syndrome Manufacturing Cost Analysis

7.1 Dry Eye Syndrome Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Dry Eye Syndrome

7.4 Dry Eye Syndrome Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Dry Eye Syndrome Distributors List

8.3 Dry Eye Syndrome Customers

9 Dry Eye Syndrome Market Dynamics

9.1 Dry Eye Syndrome Industry Trends

9.2 Dry Eye Syndrome Market Drivers

9.3 Dry Eye Syndrome Market Challenges

9.4 Dry Eye Syndrome Market Restraints

10 Global Market Forecast

10.1 Dry Eye Syndrome Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Dry Eye Syndrome by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Dry Eye Syndrome by Type (2023-2028)

10.2 Dry Eye Syndrome Market Estimates and Projections by Distribution Channel

10.2.1 Global Forecasted Sales of Dry Eye Syndrome by Distribution Channel (2023-2028)

10.2.2 Global Forecasted Revenue of Dry Eye Syndrome by Distribution Channel (2023-2028)

10.3 Dry Eye Syndrome Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Dry Eye Syndrome by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Dry Eye Syndrome by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample